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Introduction: Blood transfusion in the perioperative period has frequently been associated with an excess of
nosocomial infections. Whilst transfused whole blood induces specific host immune alteration that may predispose
to nosocomial infections, the immunomodulating properties associated with leukodepleted blood remain
incompletely understood. In this study, we explore the hypothesis that the transfusion of leukodepleted allogeneic
blood during or following major gastrointestinal surgery is associated with an immunosuppressed phenotype,
which may in turn predispose to postoperative infectious complications.
Methods: Patients aged over 45 years undergoing scheduled inpatient major gastrointestinal surgery were
recruited. Gene expression profiles of specific inflammatory genes were assayed from blood collected
preoperatively, at 24 and at 48 hours after surgery. Genes were selected based on their ability to represent
specific immune pathways. Gene expression was quantified using quantitative real-time polymerase chain
reaction (qRT-PCR) to measure messenger RNA (mRNA) levels. Postoperative infections were documented using
predefined criteria.
Results: One hundred and nineteen patients were recruited. Fifteen (13%) patients required blood transfusion
within 24 hours of surgery, 44 (37%) patients developed infections and 3 (2%) patients died prior to discharge.
Patients receiving a blood transfusion were more likely to develop postoperative infections (P =0.02) and to have
lower tumour necrosis factor alpha (TNFα), interleukin (IL)-12, IL-23 and RAR-related orphan receptor gamma T
(RORγt) gene expression in the postoperative period (P <0.05). The TNFα/IL-10 mRNA ratio at 24 hours (P =0.0006)
and at 48 hours (P =0.01) was lower in patients receiving a blood transfusion over this period. Multivariable analysis
confirmed that these observations were independent of the severity of the surgical insult.
Conclusions: An association between an immunosuppressive pattern of gene expression and blood transfusion
following major elective gastrointestinal surgery is described. This gene expression profile includes a reduction in
the activity of innate immunity and T helper cell type 1 (Th1) and T helper cell type 17 (Th17) pathways in those
patients receiving a blood transfusion. Blood transfusion was also associated with an excess of infectious
complications in this cohort. A mechanistic link is suggested but not proven.* Correspondence: michael.odwyer@bartshealth.nhs.uk
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The immunomodulating qualities of allogenic blood trans-
fusion have long been appreciated and have even been
exploited to prevent renal allograft rejection in the era
prior to the development of effective immunosuppressant
drugs [1]. The unintended clinical consequences of im-
mune modulation by allogenic blood in the perioperative
period include an increased susceptibility to infectious
complications and cancer recurrence [2,3]. As inpatient
non-cardiac surgery has recently been associated with
much higher than anticipated mortality rates, it is now
imperative that all potentially avoidable causes of excess
morbidity in this population are investigated and ad-
dressed [4]. Whilst preoperative anaemia is associated
with a doubling of inhospital mortality, it remains unclear
whether the anaemia itself or its treatment with allogeneic
blood is responsible [5]. Furthermore, perioperative
blood transfusions are not universally associated with
an increase in complications particularly when patients
receiving leukodepleted blood are included [2,6]. Also
lacking from the current literature is an analysis of alter-
ations in key inflammatory pathways associated with the
transfusion of leukodepleted blood following major elect-
ive surgery, although our group has recently described an
association between blood transfusion following severe
traumatic injury, an anti-inflammatory pattern of gene ex-
pression and an excess of infectious complications [7].
It has been repeatedly demonstrated that messenger
RNA (mRNA), assayed using real-time polymerase chain
reaction (RT-PCR), can be used to accurately quantify pat-
terns of gene expression [8-10]. Furthermore, careful selec-
tion of key regulatory and effector cytokines in conjunction
with transcription factors specific to T cell subtypes allow
inferences to be made as to the activity of specific inflam-
matory pathways related to T-helper (Th) cell development
[11]. For example, an analysis that combines gene expres-
sion data relating to the key Th1-promoting cytokine, inter-
leukin (IL)-12, the main Th1 effector cytokine, interferon
gamma (IFNγ) and the Th1-specific transcription factor
T-bet may be descriptive of the general activity of the
Th1 pathway. A similar approach can aid in the descrip-
tion of T-helper cell type 2 (Th2), Th17 and T regulatory
(Treg) cell pathways. This methodology has been previously
utilised to predict perioperative infectious complications
based on alterations in T cell pathways [10].
In this study, we explore the hypothesis that blood
transfusion during and following major elective gastro-
intestinal surgery is associated with an immunosuppressive
pattern of gene expression, which may enhance susceptibil-
ity to later infectious complications.
Methods
This prospective cohort study was conducted at The Royal
London Hospital, London UK and University CollegeHospital, London between June 2012 and November
2013. Ethical approval was granted by the North Wales
Ethics Committee (Reference: 10/WNo03/25) and this
research was conducted in compliance with the Helsinki
Declaration. Each patient on a weekday elective operating
list was screened. Eligible patients were then approached
for written informed consent. Entry into the study did not
influence the patient’s clinical treatment course in any
way. In our institution, scheduled postoperative intensive
care unit (ICU) admission is mandated for specific
surgical procedures. Based on an individual patient’s
co-morbidities the surgical or anaesthesia teams may also
request postoperative ICU treatment. All patients received
perioperative prophylactic antibiotic treatment as outlined
in Additional file 1.
Patient selection
Patients aged over 45 years undergoing scheduled surgery
involving the gastrointestinal tract, requiring a general
anaesthetic and at least an overnight hospital stay were
considered eligible for inclusion to this study. Exclusion
criteria were emergency surgery and surgery that also in-
volved access to the thoracic cavity.
Data collection
Data were collected on each patient until hospital
discharge and included information on co-morbidities,
American Society of Anesthesiology (ASA) physical status
classification [12] indication for surgery, cancer diagnosis,
duration of the procedure, planned postoperative ICU
admission and inhospital mortality. Preoperative im-
munosuppression was defined as the administration of
chemotherapeutic agents and/or radiotherapy within the
six months preceding surgery. The timing of any blood
products administered was recorded for each patient dur-
ing the first 24 hours. All packed red blood cells (PRBC)
administered were leukocyte depleted prior to storage,
included a standard sodium chloride, adenine, glucose,
mannitol (SAGM) additive solution and had a maximum
age of 35 days. Patients were examined daily by the clin-
ical team for the presence of infection, which was then
recorded by the research team following discussions with
ICU physicians, surgeons or microbiologists where neces-
sary. Definitions of infection were agreed prospectively by
the investigators and were based on the Center for Disease
Control and Prevention definitions and graded using the
Clavien-Dindo classification (see Additional file 2) [13].
Blood sampling and laboratory techniques
Blood samples were taken immediately before induction
of anaesthesia (0 hours), at 24 and 48 hours following
the operation. At each time point blood was collected in
a PAXGene™ blood RNA tube (PreAnalytix, Hilden,
Germany). Total RNA was extracted using PAXGene™
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their integrity and reverse transcribed to complementary
DNA (cDNA) [11]. Genes were selected to reflect key
elements of specific immune pathways (Table 1). Gene
expression was quantified using quantitative real-time
polymerase chain reaction (qRT-PCR). qRT-PCRs were
performed using Taqman assays (Applied Biosystems,
Foster City, CA, USA), which spanned the final two exons
of the most common isoform of each gene, and were car-
ried out on a 7900HT, Life Tech (Applied Biosystems,
Foster City, CA, USA) as previously described [7]. Each
sample was assayed in triplicate. Reference genes (β2 mi-
croglobulin (B2M) and ubiquitin C (UBC)) were selected
empirically from a panel of six [14]. Relative quantification
was calculated using the standard delta delta methodology
[15]. Results were expressed as a normalized ratio of can-
didate gene/reference gene.
Statistical analysis
Results are expressed as median and interquartile range
(IQR) or odds ratios (OR) with 95% confidence intervalsTable 1 Selected cytokines and transcription factors and
their related pathways
Gene Immune pathway Contributes to anti (-) or
pro (+) inflammatory
phenotypea
TNFα (TNF)b Common end product of
many innate and adaptive
immune pathways
+
IFNγ (IFNG)b Th1 effector cytokine +
IL-12 (IL12A)b Promotes differentiation
to Th1 effector cells
+
T-bet (TBX21)b Transcription factor utilised
by Th1 cells
+
IL-23 (IL23A)b Promotes differentiation
to Th17 phenotype
+
IL-27 (IL27)b Inhibits differentiation
to Th17 phenotype
-
RORγT (RORC)b Transcription factor utilised
by Th17 cells
+
IL-10 (IL10)b Anti-inflammatory cytokine
produced by many T cell
subtypes and some
macrophages
-
Foxp3 (FOXP3)b Transcription factor utilised
by naturally occurring CD4+
CD25+ Treg cells
-
GATA3 (GATA3)b Transcription factor utilised
by Th2 cells
-
aCytokines and transcription factors will have diverse actions under different
conditions and the descriptions above are primarily for illustrative purposes
and are not exhaustive; bdenotes official gene name as described by the
HUGO Gene Nomenclature Committee (HGNC). Foxp3, forkhead box P3;
GATA3, GATA-binding protein 3; IFNγ, interferon gamma; IL-12, interleukin 12;
IL-23, interleukin 23; IL-27, interleukin 27; RORγt, RAR-related orphan receptor
gamma T; Th1, T-helper cell type 1; Th17, T-helper cell type 17; Th2, T-helper
cell type 2; TNFɑ, tumour necrosis factor alpha; Treg, T regulatory cell.(CI). All statistical tests are two-sided and a P value of
P <0.05 was considered significant. Differences in cate-
gorical variables were calculated using a chi-squared or
Fisher’s exact test as appropriate. The Kruskal-Wallis test
was utilised for continuous variables.
Multivariable linear regression models assessed whether
gene expression was independently associated with blood
transfusion. A model was constructed in each case where
gene expression was demonstrated to be associated with
blood transfusion on a univariate analysis. Gene expression
was then selected as the dependent variable following log
transformation of the mRNA levels. A univariate analysis
then assessed the relationship between gene expression
and age, sex, duration of operation, ASA physical status
classification, cancer diagnosis and preoperative immu-
nosuppression. If this univariate analysis demonstrated
a P value <0.1 then that variable was added to the above
model as an independent variable. Backwards elimination
on non-significant variables was performed when appro-
priate (see Additional file 3).
A multivariable logistical regression analysis assessed
whether infectious complications were independently
associated with blood transfusion. The occurrence of
infectious complications was the dependent variable
and the threshold for inclusion of other variables was
again P <0.1, with variables selected from Table 2 (see
Additional file 4).
Data analysis was performed using the JMP (version 11)
statistical software package (SAS Institute Inc., Cary,
NC, USA).
Results
Patients
A total of 119 patients (mean age 65, range 57 to 72,
62% male) undergoing elective major abdominal surgery
were included in this study. Fifteen (13%) patients received
a blood transfusion. Forty-four (37%) patients developed a
postoperative infection. Three (2.5%) patients died prior
to hospital discharge. Patient characteristics are shown in
Tables 2 and 3.
Blood transfusion
In total 15 (13%) patients were transfused over the
24 hours following the commencement of surgery. The
median number of units of PRBCs transfused in this
group was 2 (IQR 1 to 2). Ten of these 15 patients re-
ceived an intraoperative transfusion, 8 of these 15 received
their transfusion in the postoperative period and, there-
fore, 3 of the 15 patients received a transfusion both intra-
operatively and postoperatively. No other blood product
was transfused during this time period. Older patients
(P =0.0002) and those with a diagnosis of cancer (P =0.02)
were more likely to receive PRBC transfusions. Smokers
were less likely to receive a blood transfusion (P =0.04).
Table 2 Characteristics of patients developing infections
and those remaining infection-free following scheduled
abdominal surgery
Infection,
n =44 (37%)
Infection-free,
n =75 (63%)
P value
Age (years) 66 (59-75) 64 (56-71) 0.19
Male sex (%) 61 63 >0.99
Diabetes (%) 18 16 0.80
Current smokers (%) 23 19 0.64
Smoking history (%) 48 57 0.34
Cancer diagnosis (%) 55 71 0.10
Preoperative
immunosuppression (%)
14 14 >0.99
Duration of operation
(minutes)
243 (176-313) 195 (142-295) 0.06
Endoscopic surgery (%) 18 32 0.13
Planned postoperative
intensive care unit
admission (%)
77 66 0.22
ASA grade 3 or 4 (%) 30 31 >0.99
By surgical specialty n (%)
General surgery 4 (44) 5 (55)
Upper gastrointestinal 9 (33) 18 (67)
Colorectal 18 (37) 31 (63)
HPB 11 (37) 19 (63)
HPB + colorectal 1 (33) 2 (67)
General surgery + colorectal 1 (100) 0 (0) 0.84a
Intraoperative blood
transfusion (%)
14 5 0.17
Blood transfusion in the
first 24 hours (%)
23 7 0.02
Inhospital death n (%) 1 (2%) 2 (2.5%) >0.99
Data are described as medians with interquartile range or numbers with
percentages in parenthesis. mRNA levels are expressed as a relative quantification
ratio between the candidate and the reference genes. aRepresents a Fisher’s exact
test incorporating all surgical specialties. ASA, American Society of
Anesthesiology; HPB, Hepato-Pancreato-Biliary.
Table 3 Characteristics of patients requiring
perioperative blood transfusion following scheduled
abdominal surgery
Transfused,
n =15 (13%)
Not transfused,
n =103 (87%)
P value
Age (years) 77 (72-81) 63 (56-70) 0.0002
Male sex (%) 60 62 1.0
Diabetes (%) 20 17 0.72
Current smokers (%) 0 23 0.04
Smoking history (%) 27 58 0.02
Cancer diagnosis (%) 93 60 0.02
Preoperative
immunosuppression (%)
29 12 0.10
Duration of operation
(minutes)
240 (150-400) 212 (145-296) 0.26
Endoscopic surgery (%) 13 29 0.35
Planned postoperative
intensive care unit
admission (%)
87 68 0.22
ASA grade 3 or 4 (%) 50 28 0.18
By surgical specialty n (%)
General surgery 0 (0) 8 (7)
Upper gastrointestinal 4 (27) 23 (22)
Colorectal 5 (33) 44 (43)
HPB 5 (33) 25 (24)
HPB + colorectal 1 (7) 2 (2)
General surgery +
colorectal
0 (0) 1 (1) 0.65a
Postoperative
infections n (%)
10 (66%) 34 (33%) 0.02
Inhospital death n (%) 2 (13%) 1 (1%) 0.04
Data are described as medians with interquartile range or numbers with
percentages in parenthesis. mRNA levels are expressed as a relative
quantification ratio between the candidate and the reference genes.
aRepresents a Fisher’s exact test incorporating all surgical specialties. ASA,
American Society of Anesthesiology; HPB, Hepato-Pancreato-Biliary.
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the duration of the operation, whether the procedure was
endoscopic or open or the ASA grade (Table 3). Patients
receiving PRBC transfusions were more likely to develop
postoperative infections (OR 5.5 (1.3 to 12.8); P =0.02
(Fisher’s exact test), Figure 1A) and were more likely to die
inhospital (OR 15.7 (1.3 to 185.3); P =0.04 (Fisher’s exact
test), Figure 1B).Blood transfusion and gene expression
On univariate analysis, IL-12 mRNA levels at 24 hours
(P =0.02) and tumour necrosis factor alpha (TNFα)
mRNA levels at 48 hours (P =0.01) were lower in those
who received a blood transfusion in the first 24 hours
postoperatively. IL-23 mRNA levels at 24 hours (P =0.007)and at 48 hours (P =0.03) and RAR-related orphan
receptor gamma T (RORγt) mRNA levels at 24 hours
(P =0.004) and at 48 hours (P =0.006) were lower in
those receiving a blood transfusion over the first 24 hours
postoperatively. The TNFα/IL-10 mRNA ratio at 24 hours
(P =0.0006) and at 48 hours (P =0.01) was lower in
patients receiving blood transfusion over this period
(Figure 2A-H).
Forkhead box P3 (Foxp3) mRNA levels at 24 hours
(P =0.004) and at 48 hours (P =0.02) and GATA-binding
protein 3 (GATA3) mRNA levels at 24 hours (P =0.02)
were lower in those who received blood transfusion in the
initial 24 hours postoperatively. IL-10, IFNγ, T-bet and
IL-27 mRNA levels were unrelated to blood transfusion.
The number of units of blood transfused was unrelated
to gene expression.
Figure 1 Perioperative blood transfusion, infectious complications and survival. Graph A represents the proportions of patients developing
postoperative infectious complications amongst those patients receiving a blood transfusion in the first 24 hours and in those patients not
receiving a blood transfusion during this time period. Graph B represents the proportions of patients either dying in hospital or surviving to
hospital discharge amongst those patients that received a blood transfusion in the first 24 hours (2 patients died out of a total of 15) and in
those patients that did not receive a blood transfusion during this time period (1 patient died out of a total of 104).
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The age of the blood was calculated as the number of days
from collection from a blood donor to transfusion. The
mean age of the transfused blood was 23 days (standard
deviation 5.9 days, range 11 to 33 days). No association was
detected between the mean age of the units of blood
transfused and gene expression for any of the selected
genes.
Postoperative infections
Forty-four (37%) patients developed postoperative infec-
tions as an inpatient a median of 9 (IQR 5 to 11) days
following the operation. The sites of infection and isolated
organisms are shown in Table 4. Patients developinginfections stayed longer in hospital (7 (5 to 10) vs. 14 (8 to
19) days, P <0.0001). With the exception of perioperative
blood transfusion, a range of demographic and clinical data
did not adequately distinguish between those who did and
did not develop infection (Table 2).
Inhospital mortality
Three (2.5%) patients died in hospital. Age, diabetes,
smoking history, ASA, length of operation, cancer diagno-
sis, planned ICU admission, preoperative immunosuppres-
sion or postoperative infections were not associated with
inhospital mortality. The requirement for blood transfusion
in the first 24 hours postoperatively was associated with a
greater mortality (P =0.04; Figure 1B).
Figure 2 Perioperative blood transfusion and gene expression: Graphs A-H represent the mRNA levels of IL-12 at 24 hours, TNFα at
48 hours, IL-23 at 24 and 48 hours, RORγt at 24 and 48 hours and the ratio of TNFα/IL-10 at 24 and 48 hours following scheduled
abdominal surgery in those patients that received a transfusion prior to this time point and in those patients that did not. Graphs
represent median and 75th percentile. Results are expressed as a relative quantification ratio between the candidate and the reference genes.
IL-10, interleukin 10; IL-12, interleukin 12; IL-23, interleukin 23; mRNA, messenger RNA; RORγt, RAR-related orphan receptor gamma T; TNFɑ,
tumour necrosis factor alpha.
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Selection of variables to be included in the multivariate
analysis is described in the Methods section. IL-12, RORγt,
TNFα/IL-10 and Foxp3 mRNA levels at 24 hours along with
RORγt, TNFα/IL-10 and Foxp3 mRNA levels at 48 hours
were independently associated with transfusion in the first
24 hours (see Additional file 3). There was no independent
association between GATA3 and IL-23 mRNA levels at
24 hours and between IL-23 and TNFα mRNA levels at
48 hours and blood transfusion within the first 24 hours.
There was an independent association between the
occurrence of infectious complications and the require-
ment for blood transfusion in the first 24 hours postoper-
atively (see Additional file 4).Differential leucocyte count and gene expression
In order to assess for an association between perioperative
variations in white blood cell subpopulations and gene
expression, changes in neutrophil, lymphocyte, monocyte
and eosinophil counts over the initial 24 hours were
compared with changes in individual gene expression over
the same period (see Additional file 5). Thirty-six compar-
isons were generated. Of these, just two attained a level of
statistical significance with P <0.05 before correcting for
multiple comparisons. An association was noted between
increasing IL-10 mRNA levels and increasing neutrophil
counts (r2 = 0.06, P =0.01) and between decreasing
lymphocyte counts and increasing IL-10 mRNA levels
(r2 = 0.05, P =0.02).
Table 4 A description of the infectious complications in the
postoperative period
Infection site Number
of
episodes
Organisms Median time to
development of
infection (days)
Bloodstream
infection
11 Escherichia coli (4) 17 (6-28)
ESBL E. coli (1)
E. coli + Enterococcus
faecium (1)
E. faecium (1)
Klebsiella pneumoniae (1)
Staphylococcus aureus (1)
Pseudomonas
aeruginosa (2)
Pneumonia 9 Culture negative (5) 7 (4-16)
Candida glabrata (1)
K. pneumoniae (1)
Organism of the
coliform group (1)
Stenotrophomonas
maltophilia (1)
Wound
infection
24 Culture negative (11) 10 (4-14)
Bacteroides fragilis (1)
E. coli (4),
ESBL E. coli (1)
Mixed anaerobes (1)
Organism of the
coliform group (2)
Organism of the
coliform group +
E. faecalis (1)
Organism of the
coliform group +
MRSA (1)
Organism of the
coliform group +
S. aureus (1)
P. aeruginosa (1)
Urinary tract
infection
15 Candida albicans (1) 8 (6-12)
Culture negative (2)
E. coli (6)
ESBL E. coli (1)
Mixed growth (2)
Organism of the
coliform group (2)
P. aeruginosa (1)
Intra-abdominal
infection
17 Culture negative (6) 9 (7-14)
E. coli (2)
E. coli + E. faecium (1)
ESBL E. coli + VRE (1)
E. faecalis (1)
Table 4 A description of the infectious complications in the
postoperative period (Continued)
E. faecium +
Candida albicans (1)
C. albicans (1)
Enterobacter cloacae (1)
E. cloacae + Organism
of the coliform
group (1)
E. aerogenes +
P. aeruginosa (1)
VRE (1)
Intravascular
catheter-
related
infection
2 K. pneumoniae (1) 15 (3-27)
Organism of the
coliform group (1)
Skin infection 1 Varicella zoster
virus (VZV)
30
Data refer to the number of episodes of infection from a particular site. Some
patients may have more than one episode of infection. The number in
parenthesis in the ‘organisms’ column the number of episodes of infection
attributable to that organism. Data are described as median and interquartile
range. ESBL, extended-spectrum beta-lactamase; MRSA, methicillin-resistant
Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus.
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In this study we determined levels of mRNA for a panel of
interlinked cytokines and related transcription factors and
demonstrated that those patients receiving a perioperative
blood transfusion following major gastrointestinal surgery
displayed a pattern of gene expression consistent with
greater immunosuppression when compared with a cohort
not receiving a blood transfusion. This observation was
independent of variables descriptive of the extent of surgi-
cal trauma. The gene expression data presented suggests
that blood transfusion in this setting may be associated with
specific immune defects in innate immunity and in Th1
and Th17 pathways. These patients also had an excess of
postoperative infectious complications when compared
with patients that did not receive a blood transfusion; an
observation that was again independent of the duration of
the surgical procedure.
The genes selected as candidates in this study are well
described as surrogate measures of the specific immune
pathways outlined in Table 1 [10,11,16]. Furthermore, the
construction of a ratio of gene expression that incorporates
the prototypical proinflammatory cytokine, TNFα, and the
archetypal anti-inflammatory cytokine, IL-10, permits the
concurrent assessment of both major facets of the immune
response and has previously been utilised to predict post-
operative outcome [17]. Whilst the observed reductions in
TNFα and IL-12 gene expression are indicative of impaired
innate immunity and Th1 pathways respectively and the
reduction in IL-23 and RORγt is indicative of reduced Th17
activity, these data should not be interpreted as being con-
clusive. Flow cytometry experiments would be necessary to
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barriers and are ideally not performed on stored samples
[18]. The Th1 pathway is an essential link between innate
and adaptive immunity and Th1 effector cells are particu-
larly important for effective bactericidal activity against
intracellular pathogens [19]. Th17 cells are a branch of the
adaptive immune system and appear to deal primarily with
organisms inadequately subdued by Th1 or Th2 immunity
and that seem to require a very robust inflammatory
response [20]. It is biologically plausible that an acquired
immune deficit involving these pathways could lead to an
increased susceptibility to opportunistic infections with the
pathogens encountered in the perioperative period.
Although numerous small studies have suggested that
perioperative allogenic blood transfusion may induce
immune modulations that create an environment that pro-
motes both microbial growth and tumorigenesis their con-
clusions are limited by small cohort size, in vitro and
ex vivo assays and insensitive protein assays [3,21-26]. In
addition, these studies largely predate the routine leuko-
depletion of transfused blood and suggest a causal relation-
ship between immune modulation and the infusion of
allogeneic leukocytes; a biological effect that could be
ameliorated by pre-storage leukodepletion [22]. It cannot
therefore be inferred that a similar immunological response
will be observed following exposure to a leukodepleted
product. In contrast, the packed red cells transfused in
the study reported here were universally leukodepleted.
Furthermore, the use of qRT-PCR in this study to assay
gene expression allows for a validated ultrasensitive tech-
nique to assess immune pathways in the in vivo state
[8-11]. The results we present suggest that the immunosup-
pression observed following perioperative transfusion may
not be solely dependent on the presence of allogeneic
leukocytes in the transfused blood. However, despite a 3 log
reduction in leukocyte numbers achieved following current
filtration techniques some leukocytes do persist and these
retain the ability to influence host immune responses [22].
Recently, using a similar methodology we described an
excess of infectious complications amongst severely
injured trauma patients receiving leukodepleted blood
transfusion in conjunction with a gene expression profile
characterised by specific deficits in Th1 and Th17 path-
ways [7]. The similarities between these results are notable
given that there were important differences in the patient
populations. The trauma cohort were younger (median
age 41), had a higher incidence of early blood transfusion
(64%) and received greater volumes of PRBCs within the
initial 24 hours (median 4 units) in conjunction with
additional blood products. In addition, the trauma cohort
are likely to have endured a greater physiological insult
given a higher mortality rate (19%) and also a greater
incidence of nosocomial infections (63%). Clearly, patients
that receive a blood transfusion outside of the context of arandomised controlled trial will differ from those that do
not require transfusion and it is important to attempt to
control for these factors. In the previously reported
trauma cohort the described observations were independ-
ent of the severity of injury and degree of shock at presen-
tation [7]. Similarly, in this perioperative cohort, although
on univariate analysis there was a trend towards longer
and therefore potentially more complicated surgery being
associated with postoperative infections and to a lesser
degree with blood transfusion, a multivariable analysis
confirmed that the association between blood transfusion
and both infectious complications and gene expression
patterns were independent of the duration of surgery.
Although we describe an association between blood trans-
fusion, an immunosuppressive pattern of gene expression
and excess infectious complications, it may be that,
despite adjustment for known confounders, the need for
blood transfusion is a surrogate marker of severity of
surgical stress or an unmeasured premorbid condition
and thus a causative role in postoperative immune pheno-
type is suggested but not proven. However, the consis-
tency of these data from two distinct patient populations,
post major gastrointestinal surgery patients and trauma
patients, strengthens our underlying hypothesis.
The association between blood transfusion and infectious
complications in the perioperative period has been well
described previously [2,3,27]. This association appears to be
consistent amongst cohorts that received either whole
blood or leukodepleted blood. The magnitude of the effect
size is potentially quite substantial with one recent estimate
quantifying the increased risk of infection at 29% for each
unit of blood transfused [27]. That we were able to describe
a similar association between blood transfusion and noso-
comial infection in a smaller cohort of patients may be
related to this effect size, in addition to the selection of an
at-risk population using patient age, gastrointestinal surgery
under general anaesthesia and the requirement for inpatient
treatment as inclusion criteria. We did not, however, record
blood transfusions that were administered following the ini-
tial 24 hours postoperatively. The postoperative infection
rates we report are consistent with similar patient popula-
tions [28]. This study also described an association between
blood transfusion and mortality. However, whilst the
mortality rate is consistent with similar populations [28],
with only three deaths occurring in the cohort as a whole,
no conclusions regarding causation should be inferred from
this association.
It is unsurprising that we did not observe an association
between increasing age of the transfused blood and either
perioperative infectious complications or patterns of gene
expression as this study was underpowered to detect such
an association. There is much current debate surrounding
the potential pathogenicity associated with blood stored for
excessive periods prior to transfusion. In the perioperative
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an excess of infectious complications [29-31]. The results of
a randomised controlled trial comparing blood stored for
under a week with older blood in intensive care patients are
awaited and will provide important and relevant data [32].
Conclusions
Our data suggest that the transfusion of leukodepleted
allogeneic blood during or immediately after major gastro-
intestinal surgery is associated with patterns of gene expres-
sion consistent with immunosuppression and specific
deficiencies in innate immunity and Th1 and Th17 proin-
flammatory immune pathways. A mechanistic link between
allogenic perioperative blood transfusion, defects in essen-
tial bactericidal pathways and an excess of nosocomial
infections is suggested but not proven. Further research is
necessary in order to prove causation.
Key messages
 Perioperative blood transfusion is associated with an
excess of nosocomial infections.
 Perioperative blood transfusion is associated with a
specific gene expression profile indicative of immune
suppression that could predispose patients to
nosocomial infections.
Additional files
Additional file 1: Antibiotic prophylaxis for GI surgery in adults.
Institutional guidelines for perioperative antibiotic prophylaxis in adult
patients undergoing gastrointestinal surgery.
Additional file 2: Criteria used for defining the sites of infection.
Criteria used for defining the infection sites based on the Center for
Disease Control and Prevention definitions [13].
Additional file 3: Multivariable linear regression analysis for
prediction of gene expression. Multivariable linear regression analysis
of gene expression using requirement for blood transfusion, diagnosis
of cancer, duration of the surgical procedure, age, ASA class and the
presence of preoperative immunosuppression transfusion as potential
independent variables. Selection of variables is described in the Methods
section.
Additional file 4: Multivariable logistical regression analysis for
postoperative infections. Multivariable logistical regression analysis of
postoperative infections using cancer diagnosis, duration of surgery and
transfusion with the first 24 hours postoperatively as independent
variables. Selection of variables is described in the Methods section.
Additional file 5: A comparison of changes in leucocyte
subpopulations with changes in candidate gene expression.
Changes in leucocyte subpopulations over the perioperative period are
expressed by calculating a ratio of the cell count at 24 hours to the
preoperative cell count. The same calculation was used to assess the
change in gene expression over the same period.
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